全文获取类型
收费全文 | 2267篇 |
免费 | 119篇 |
国内免费 | 82篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 61篇 |
妇产科学 | 44篇 |
基础医学 | 235篇 |
口腔科学 | 40篇 |
临床医学 | 249篇 |
内科学 | 506篇 |
皮肤病学 | 86篇 |
神经病学 | 58篇 |
特种医学 | 323篇 |
外国民族医学 | 2篇 |
外科学 | 380篇 |
综合类 | 40篇 |
预防医学 | 174篇 |
眼科学 | 29篇 |
药学 | 88篇 |
中国医学 | 5篇 |
肿瘤学 | 133篇 |
出版年
2023年 | 13篇 |
2022年 | 18篇 |
2021年 | 29篇 |
2020年 | 22篇 |
2019年 | 40篇 |
2018年 | 68篇 |
2017年 | 37篇 |
2016年 | 44篇 |
2015年 | 51篇 |
2014年 | 61篇 |
2013年 | 86篇 |
2012年 | 127篇 |
2011年 | 103篇 |
2010年 | 96篇 |
2009年 | 99篇 |
2008年 | 84篇 |
2007年 | 117篇 |
2006年 | 85篇 |
2005年 | 111篇 |
2004年 | 66篇 |
2003年 | 64篇 |
2002年 | 60篇 |
2001年 | 57篇 |
2000年 | 68篇 |
1999年 | 43篇 |
1998年 | 91篇 |
1997年 | 78篇 |
1996年 | 69篇 |
1995年 | 56篇 |
1994年 | 51篇 |
1993年 | 49篇 |
1992年 | 35篇 |
1991年 | 20篇 |
1990年 | 29篇 |
1989年 | 45篇 |
1988年 | 43篇 |
1987年 | 35篇 |
1986年 | 28篇 |
1985年 | 27篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1980年 | 14篇 |
1979年 | 9篇 |
1978年 | 8篇 |
1977年 | 18篇 |
1976年 | 19篇 |
1975年 | 13篇 |
1969年 | 4篇 |
排序方式: 共有2468条查询结果,搜索用时 15 毫秒
1.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
2.
A G Assounga S Bascoul B Canaud P A Bouya J P Vendrell J P Sciolla G Mourad P Baldet A Serre C Mion 《American journal of kidney diseases》1990,15(6):556-561
This study reports on beta 2-microglobulin (beta 2M) deposits in the skin of 12 uremic patients and three kidney transplant recipients compared with eight healthy controls. Uremic patients were treated by hemodialysis (HD), hemofiltration (HF), hemodiafiltration (HDF), or continuous ambulatory peritoneal dialysis (CAPD) for a period lasting from 1 to 19 years. Congo red staining of the skin was negative in patients and controls. However, immunofluorescent staining with an anti-beta 2-microglobulin monoclonal antibody was positive in the skin of all patients and of six of the eight controls. Beta 2M skin deposition is more intense in patients than in controls and increases with patient age and the duration of dialysis. A stron correlation is observed between the extent of skin beta 2M deposits and clinical manifestations due to beta 2M deposits in internal organs. However, no correlation is found between beta 2M skin deposits and sex or beta 2M serum levels. 相似文献
3.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
4.
5.
6.
7.
SUMMARY A young patient presenting with splenomegaly and hypersplenism was inadvertently found to have selective IgA deficiency. There were no symptoms of immunodeficiency and the patient responded well to splenectomy, with return of blood counts to normal without adverse effects. No other cause for the hypersplenism was found. We postulate selective IgA deficiency as a cause of splenomegaly and hypersplenism. 相似文献
8.
Abdelfettah Abid Raouf Denguir Karim Kaouel Mourad Hakim Imed Khanfir Taoufik Kalfat Adel Khayati 《La Tunisie médicale》2003,81(1):67-71
The aim of this study is to raise up the effect of surgical thrombectomy among other alternative therapies. This retrospective study reports 6 patients (mean age 63 years) admitted with phlegmasia cerulea dolens. All patients underwent surgical venous thrombectomy associated with infracava filter insertion in 2 cases. One patient died in the early postoperative course. In all other cases we noticed good early and late outcome both on clinical examination and duplex scanning assessment. In conclusion, surgical venous thrombectomy can be considered as a good and efficient procedure in the presence of phlegmasia cerulea dolens in order to relieve ischemia and to prevent whenever possible severe chronic venous disorders. However, fibrinolytic therapy might achieve as good results as surgery. Thus, the latter is to be reserved to very severe veinous ischemia with limb loss threatening where fibrinolytic therapy fails or is contre-indicated. 相似文献
9.
10.
V. Haufroid P. Wallemacq V. VanKerckhove L. Elens M. De Meyer D. C. Eddour J. Malaise D. Lison M. Mourad 《American journal of transplantation》2006,6(11):2706-2713
Genetic polymorphisms in biotransformation enzyme CYP3A5 (6986G > A, CYP3A5*3; 14690A > G, CYP3A5*6) and drug transporter ABCB1 (1236C > T; 2677G > T/A; 3435C > T) are known to influence tacrolimus (Tac) dose requirements and trough blood levels in stable transplant patients. In a group of 19 volunteers selected with relevant genotypes among a list of 221 adult renal transplant candidates, we evaluated whether consideration of CYP3A5 and ABCB1 genetic polymorphisms could explain the interindividual variability in Tac pharmacokinetics after the first administration of a standard dose (0.1 mg/kg body weight twice a day). Lower area under the time versus blood concentration curves (AUC) or lower trough concentrations were observed among CYP3A5 expressors (n = 9) than among nonexpressors (n = 10) using two different analytical methods for Tac determination (liquid chromatography with tandem mass spectrometry (LC-MS/MS) and immunoassay). The median AUC(0-infinity) was 2.6- and 2.1-fold higher in nonexpressors for LC-MS/MS and immunologic methods, respectively. No difference was observed in Tac pharmacokinetic parameters in relation to ABCB1 polymorphisms. In conclusion, our study confirms the very significant effect of CYP3A5 polymorphism early after the first administration of Tac. It also provides a strong argument for a doubling of the loading dose in patients early identified a priori on the transplantation list as possessing at least one CYP3A5*1 allele. 相似文献